vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Distribution Solutions Group, Inc. (DSGR). Click either name above to swap in a different company.
Distribution Solutions Group, Inc. is the larger business by last-quarter revenue ($518.0M vs $284.0M, roughly 1.8× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 1.2%, a 95.1% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
ACAD vs DSGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $518.0M |
| Net Profit | $273.6M | $6.5M |
| Gross Margin | 90.8% | 32.9% |
| Operating Margin | 6.1% | 4.6% |
| Net Margin | 96.3% | 1.2% |
| Revenue YoY | 9.4% | 10.7% |
| Net Profit YoY | 90.3% | -70.6% |
| EPS (diluted) | $1.61 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $518.0M | ||
| Q2 25 | $264.6M | $502.4M | ||
| Q1 25 | $244.3M | $478.0M | ||
| Q4 24 | $259.6M | $480.5M | ||
| Q3 24 | $250.4M | $468.0M | ||
| Q2 24 | $242.0M | $439.5M | ||
| Q1 24 | $205.8M | $416.1M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $6.5M | ||
| Q2 25 | $26.7M | $5.0M | ||
| Q1 25 | $19.0M | $3.3M | ||
| Q4 24 | $143.7M | $-25.9M | ||
| Q3 24 | $32.8M | $21.9M | ||
| Q2 24 | $33.4M | $1.9M | ||
| Q1 24 | $16.6M | $-5.2M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | 32.9% | ||
| Q2 25 | 92.2% | 33.9% | ||
| Q1 25 | 91.7% | 34.3% | ||
| Q4 24 | 91.6% | 33.3% | ||
| Q3 24 | 92.5% | 33.9% | ||
| Q2 24 | 92.5% | 34.5% | ||
| Q1 24 | 88.8% | 34.5% |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 4.6% | ||
| Q2 25 | 12.2% | 5.3% | ||
| Q1 25 | 7.9% | 4.2% | ||
| Q4 24 | 59.1% | 4.2% | ||
| Q3 24 | 12.6% | 4.0% | ||
| Q2 24 | 12.6% | 3.2% | ||
| Q1 24 | 7.4% | 0.7% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 1.2% | ||
| Q2 25 | 10.1% | 1.0% | ||
| Q1 25 | 7.8% | 0.7% | ||
| Q4 24 | 55.4% | -5.4% | ||
| Q3 24 | 13.1% | 4.7% | ||
| Q2 24 | 13.8% | 0.4% | ||
| Q1 24 | 8.0% | -1.3% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $0.14 | ||
| Q2 25 | $0.16 | $0.11 | ||
| Q1 25 | $0.11 | $0.07 | ||
| Q4 24 | $0.86 | $-0.55 | ||
| Q3 24 | $0.20 | $0.46 | ||
| Q2 24 | $0.20 | $0.04 | ||
| Q1 24 | $0.10 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $69.2M |
| Total DebtLower is stronger | — | $665.5M |
| Stockholders' EquityBook value | $1.2B | $653.9M |
| Total Assets | $1.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $69.2M | ||
| Q2 25 | $253.6M | $47.4M | ||
| Q1 25 | $217.7M | $65.4M | ||
| Q4 24 | $319.6M | $66.5M | ||
| Q3 24 | $155.1M | $61.3M | ||
| Q2 24 | $177.1M | $46.8M | ||
| Q1 24 | $204.7M | $73.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $665.5M | ||
| Q2 25 | — | $675.0M | ||
| Q1 25 | — | $712.4M | ||
| Q4 24 | — | $693.9M | ||
| Q3 24 | — | $704.1M | ||
| Q2 24 | — | $573.7M | ||
| Q1 24 | — | $535.7M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $653.9M | ||
| Q2 25 | $822.4M | $649.4M | ||
| Q1 25 | $765.2M | $636.7M | ||
| Q4 24 | $732.8M | $640.5M | ||
| Q3 24 | $577.2M | $680.8M | ||
| Q2 24 | $516.7M | $653.3M | ||
| Q1 24 | $464.0M | $654.7M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $976.9M | $1.8B | ||
| Q2 24 | $914.1M | $1.6B | ||
| Q1 24 | $855.1M | $1.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.02× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.08× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.88× | ||
| Q1 24 | — | 0.82× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $38.4M |
| Free Cash FlowOCF − Capex | — | $32.9M |
| FCF MarginFCF / Revenue | — | 6.3% |
| Capex IntensityCapex / Revenue | — | 1.1% |
| Cash ConversionOCF / Net Profit | -0.18× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $92.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $38.4M | ||
| Q2 25 | $64.0M | $33.3M | ||
| Q1 25 | $20.3M | $-4.8M | ||
| Q4 24 | $40.4M | $45.7M | ||
| Q3 24 | $63.2M | $-17.3M | ||
| Q2 24 | $25.0M | $21.4M | ||
| Q1 24 | $29.1M | $6.6M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $32.9M | ||
| Q2 25 | — | $28.7M | ||
| Q1 25 | — | $-10.4M | ||
| Q4 24 | — | $41.1M | ||
| Q3 24 | $63.2M | $-20.5M | ||
| Q2 24 | — | $18.0M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 6.3% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -2.2% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | 25.2% | -4.4% | ||
| Q2 24 | — | 4.1% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 5.95× | ||
| Q2 25 | 2.40× | 6.66× | ||
| Q1 25 | 1.07× | -1.46× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | -0.79× | ||
| Q2 24 | 0.75× | 11.28× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
